Monoclonal Antibody Therapeutics (mABs) Market Trends and Analysis by 2031

Monoclonal Antibody Therapeutics (mABs) Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Recombinant mABs, Antibody Drug Conjugates, Bispecific and Multispecific mABs, Biosimilars, and Others), Application (Oncology, Autoimmune Disease, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

  • Status : Data Released
  • Report Code : TIPRE00003417
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Application, Distribution Channel, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is expected to witness significant demand for monoclonal antibody therapeutics market in the coming years?

Global monoclonal antibody therapeutics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share of the monoclonal antibody therapeutics market in 2022.

Which application segment held the largest share in the monoclonal antibody therapeutics market?

The autoimmune disease segment dominated the global monoclonal antibody therapeutics market and held the largest market share in 2022.

Who are the key players in the monoclonal antibody therapeutics market?

The monoclonal antibody therapeutics market majorly consists of the players such GlaxoSmithKline, F.Hoffmann-La-Roche, Bayer AG, Amgen, Novartis, AbbVie, Bristol-Myers Squibb, Janssen Pharmaceutical, Merck KgaA, and AstraZeneca, and amongst others.

What are the driving factors for the monoclonal antibody therapeutics market across the globe?

Key factors that are driving the growth of this market are production of mabs-based drugs to treat several infectious diseases is expected to boost the market growth for the monoclonal antibody therapeutics over the years.

What is the market CAGR value of monoclonal antibody therapeutics market during forecast period?

The CAGR value of the monoclonal antibody therapeutics market during the forecasted period of 2025-2031 is 13.9%.

Which product segment leads the monoclonal antibody therapeutics market?

The recombinant mABs segment held the largest share of the market in the global monoclonal antibody therapeutics market and held the largest market share in 2022.

What is monoclonal antibody therapeutics market?

Monoclonal antibody (mAbs) therapeutics is a homogenous collection of antibodies used to treat illness and are selected to target antigens. Therapeutic mAbs require a mammalian expression system offering the cell machinery required to glycosylate, fold, orient, and covalently bind antibody peptide chains to produce complete and biologically functional molecules. Also, the therapeutic antibody is expanding the use of new modality antibodies such as bispecific and trispecific antibodies to recognize the multiple epitopes on the same antigen and single domain antibodies that can more easily penetrate tissues and antibody-drug conjugates for targeting chemotherapy agents to specific cell types.

Which are the top companies that hold the market share in monoclonal antibody therapeutics market?

Amgen and GlaxoSmithKline are the top two companies that hold huge market shares in the monoclonal antibody therapeutics market.

1. Introduction

1.1 Scope of the Study

1.2 Market Definition, Assumptions and Limitations

1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Market Attractiveness Analysis

3. Research Methodology

4. Monoclonal Antibody Therapeutics Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Monoclonal Antibody Therapeutics Market - Key Market Dynamics

5.1 Key Market Drivers

5.2 Key Market Restraints

5.3 Key Market Opportunities

5.4 Future Trends

5.5 Impact Analysis of Drivers and Restraints

6. Monoclonal Antibody Therapeutics Market - Global Market Analysis

6.1 Monoclonal Antibody Therapeutics - Global Market Overview

6.2 Monoclonal Antibody Therapeutics - Global Market and Forecast to 2030

7. Monoclonal Antibody Therapeutics Market – Revenue Analysis (USD Million) – By Product, 2020-2030

7.1 Overview

7.2 Recombinant Monoclonal Antibodies (mABs)

7.3 Antibody-Drug Conjugates

7.4 Bi-Multi Specific Monoclonal Antibodies (mABs)

7.5 Biosimilars

7.6 Others

8. Monoclonal Antibody Therapeutics Market – Revenue Analysis (USD Million) – By Application, 2020-2030

8.1 Overview

8.2 Cancer

8.3 Autoimmune Diseases

8.3.1 Rheumatoid Arthritis (RA)

8.3.2 Psoriasis

8.3.3 Ulcerative Colitis

8.3.4 Others

8.4 Others

9. Monoclonal Antibody Therapeutics Market – Revenue Analysis (USD Million) – By Distribution Channel, 2020-2030

9.1 Overview

9.2 Hospital Pharmacies

9.3 Retail Pharmacies

9.4 Others

10. Monoclonal Antibody Therapeutics Market - Revenue Analysis (USD Million), 2020-2030 – Geographical Analysis

10.1 North America

10.1.1 North America Monoclonal Antibody Therapeutics Market Overview

10.1.2 North America Monoclonal Antibody Therapeutics Market Revenue and Forecasts to 2030

10.1.3 North America Monoclonal Antibody Therapeutics Market Revenue and Forecasts and Analysis - By Product

10.1.4 North America Monoclonal Antibody Therapeutics Market Revenue and Forecasts and Analysis - By Application

10.1.5 North America Monoclonal Antibody Therapeutics Market Revenue and Forecasts and Analysis - By Distribution Channel

10.1.6 North America Monoclonal Antibody Therapeutics Market Revenue and Forecasts and Analysis - By Countries

10.1.6.1 United States Monoclonal Antibody Therapeutics Market

10.1.6.1.1 United States Monoclonal Antibody Therapeutics Market, by Product

10.1.6.1.2 United States Monoclonal Antibody Therapeutics Market, by Application

10.1.6.1.3 United States Monoclonal Antibody Therapeutics Market, by Distribution Channel

10.1.6.2 Canada Monoclonal Antibody Therapeutics Market

10.1.6.2.1 Canada Monoclonal Antibody Therapeutics Market, by Product

10.1.6.2.2 Canada Monoclonal Antibody Therapeutics Market, by Application

10.1.6.2.3 Canada Monoclonal Antibody Therapeutics Market, by Distribution Channel

10.1.6.3 Mexico Monoclonal Antibody Therapeutics Market

10.1.6.3.1 Mexico Monoclonal Antibody Therapeutics Market, by Product

10.1.6.3.2 Mexico Monoclonal Antibody Therapeutics Market, by Application

10.1.6.3.3 Mexico Monoclonal Antibody Therapeutics Market, by Distribution Channel

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe

10.2.1 Germany

10.2.2 France

10.2.3 Italy

10.2.4 Spain

10.2.5 United Kingdom

10.2.6 Rest of Europe

10.3 Asia-Pacific

10.3.1 Australia

10.3.2 China

10.3.3 India

10.3.4 Japan

10.3.5 South Korea

10.3.6 Rest of Asia-Pacific

10.4 Middle East and Africa

10.4.1 South Africa

10.4.2 Saudi Arabia

10.4.3 U.A.E

10.4.4 Rest of Middle East and Africa

10.5 South and Central America

10.5.1 Brazil

10.5.2 Argentina

10.5.3 Rest of South and Central America

11. Industry Landscape

11.1 Mergers and Acquisitions

11.2 Agreements, Collaborations, Joint Ventures

11.3 New Product Launches

11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players

12.2 Company Positioning and Concentration

13. Monoclonal Antibody Therapeutics Market - Key Company Profiles

13.1 F. Hoffmann-La-Roche

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

Note - Similar information would be provided for below list of companies

13.2 AstraZeneca

13.3 Bayer AG

13.4 Merck KGaA

13.5 GlaxoSmithKline plc

13.6 Amgen

13.7 Novartis AG

13.8 AbbVie Inc.

13.9 Janssen Pharmaceuticals

13.10 Bristol-Myers Squibb Company

14. Appendix

14.1 Glossary

14.2 About The Insight Partners

14.3 Market Intelligence Cloud

Your Key Concerns Addressed - Question & Answer
Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Please use your business email for quicker response
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.